» Articles » PMID: 1709354

Conservative Treatment of Bell's Palsy with Steroids and Dextran-pentoxiphylline Combined Therapy

Overview
Date 1991 Jan 1
PMID 1709354
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In 1980, Stennert proposed for the treatment of Bell's palsy an infusion therapy consisting of initially high dosages of steroids in combination with low-molecular dextran and pentoxiphylline. Excellent results were reported as a consequence of administering this treatment scheme. This "steroid-dextran" medication was modified (SD therapy) and administered in 172 cases of Bell's palsy. The results were compared with those of a group of 59 patients who had been treated with orally administered low-dose steroids in combination with vasodilators, adenosine triphosphate and vitamins. All patients with incomplete palsies recovered completely, regardless of the mode of treatment. In cases of complete palsy, 87% of patients recovered completely when treated with SD therapy. In contrast, 68% of the patients treated with orally administered steroids recovered completely.

Citing Articles

To Determine the Efficacy of Pentoxifylline in the Management of Bell's Palsy.

Shamanna K, Krishnamurthy M Indian J Otolaryngol Head Neck Surg. 2024; 76(1):858-864.

PMID: 38440638 PMC: 10908893. DOI: 10.1007/s12070-023-04298-9.


Modified Stennert's Protocol in Treating Acute Peripheral Facial Nerve Paralysis: Our Experience.

Mahesh S, Nayak D, Balakrishnan R, Pavithran P, Pillai S, Sharma A Indian J Otolaryngol Head Neck Surg. 2014; 65(3):214-8.

PMID: 24427569 PMC: 3696149. DOI: 10.1007/s12070-011-0440-2.


Paediatric facial paralysis. Current opinion in evaluation and management.

Bhattacharyya A, Ghosh S Indian J Otolaryngol Head Neck Surg. 2012; 51(3):21-7.

PMID: 23119539 PMC: 3451039. DOI: 10.1007/BF02996523.


Management of peripheral facial nerve palsy.

Finsterer J Eur Arch Otorhinolaryngol. 2008; 265(7):743-52.

PMID: 18368417 PMC: 2440925. DOI: 10.1007/s00405-008-0646-4.


Bell's Palsy and Herpes Zoster Oticus.

Morrow Curr Treat Options Neurol. 2000; 2(5):407-416.

PMID: 11096766 DOI: 10.1007/s11940-000-0039-5.


References
1.
Tani M, Kinishi M, Takahara T, Hosomi H, AMATSU M . Medical treatment of Bell's palsy. Oral vs. intravenous administration. Acta Otolaryngol Suppl. 1988; 446:114-8. DOI: 10.3109/00016488709121853. View

2.
Stennert E . Pathomechanisms in cell metabolism: a key to treatment of Bell's palsy. Ann Otol Rhinol Laryngol. 1981; 90(6 Pt 1):577-83. DOI: 10.1177/000348948109000613. View

3.
Adour K, Wingerd J, Bell D, Manning J, Hurley J . Prednisone treatment for idiopathic facial paralysis (Bell's palsy). N Engl J Med. 1972; 287(25):1268-72. DOI: 10.1056/NEJM197212212872503. View

4.
LAUMANS E, Jongkees L . ON THE PROGNOSIS OF PERIPHERAL FACIAL PARALYSIS OF ENDOTEMPORAL ORIGIN. Ann Otol Rhinol Laryngol. 1963; 72:621-36. DOI: 10.1177/000348946307200303. View

5.
TAVERNER D, Cohen S, Hutchinson B . Comparison of corticotrophin and prednisolone in treatment of idiopathic facial paralysis (Bell's palsy). Br Med J. 1971; 4(5778):20-2. PMC: 1799156. DOI: 10.1136/bmj.4.5778.20. View